17(R)-Resolvin D1 (CAS 528583-91-7)
QUICK LINKS
17(R)-Resolvin D1 is a bioactive lipid mediator derived from docosahexaenoic acid (DHA) that plays a role in the resolution of inflammation. It is produced during the resolution phase of acute inflammation and has potent anti-inflammatory and pro-resolving properties. 17(R)-Resolvin D1 is involved in the regulation of various cellular processes, including the inhibition of pro-inflammatory cytokine production, the promotion of macrophage phagocytosis of apoptotic cells, and the reduction of neutrophil infiltration at the site of inflammation. This lipid mediator has the ability to promote tissue repair and regeneration by stimulating the production of anti-inflammatory and pro-resolving mediators. 17(R)-Resolvin D1 regulates the immune response and promote the resolution of chronic inflammation. 17(R)-Resolvin D1 is an important mediator in the resolution of inflammation and plays a role in maintaining tissue homeostasis.
17(R)-Resolvin D1 (CAS 528583-91-7) References
- Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. | Hong, S., et al. 2003. J Biol Chem. 278: 14677-87. PMID: 12590139
- Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. | Sun, YP., et al. 2007. J Biol Chem. 282: 9323-9334. PMID: 17244615
- Resolvins and protectins in the termination program of acute inflammation. | Ariel, A. and Serhan, CN. 2007. Trends Immunol. 28: 176-83. PMID: 17337246
- 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli. | Palmer, CD., et al. 2011. J Leukoc Biol. 90: 459-70. PMID: 21653234
- 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. | Bang, S., et al. 2012. Br J Pharmacol. 165: 683-92. PMID: 21718307
- Sensory TRP channel interactions with endogenous lipids and their biological outcomes. | Yoo, S., et al. 2014. Molecules. 19: 4708-44. PMID: 24739932
- Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders. | Blanchard, HC., et al. 2015. Prostaglandins Leukot Essent Fatty Acids. 96: 25-30. PMID: 25638779
- 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice. | Yatomi, M., et al. 2015. Physiol Rep. 3: PMID: 26660549
- The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of a randomized clinical trial. | Alfaddagh, A., et al. 2018. J Clin Lipidol. 12: 937-947.e2. PMID: 29752179
- Effects of chronic low-dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis. | Rohwer, N., et al. 2020. Cancer Med. 9: 2535-2550. PMID: 31994315
- Aspirin-Triggered Resolvin D1 Reduces Chronic Dust-Induced Lung Pathology without Altering Susceptibility to Dust-Enhanced Carcinogenesis. | Dominguez, EC., et al. 2022. Cancers (Basel). 14: PMID: 35454807
- GPR39 Deficiency Impairs Memory and Alters Oxylipins and Inflammatory Cytokines Without Affecting Cerebral Blood Flow in a High-Fat Diet Mouse Model of Cognitive Impairment. | Bah, TM., et al. 2022. Front Cell Neurosci. 16: 893030. PMID: 35875352
- Endothelial cell-derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis. | Ruiz, F., et al. 2023. EMBO Rep. 24: e55328. PMID: 36715148
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
17(R)-Resolvin D1, 10 µg | sc-358747 | 10 µg | $290.00 | |||
17(R)-Resolvin D1, 25 µg | sc-358747A | 25 µg | $573.00 |